Scapular Upward Rotation Exercises for Subjects With Deperessed Scapular Alignment

Effect of Scapular Upward Rotation Exercises on Neural Tissue Mechanosensitivity in Subjects With Deperessed Scapular Alignment

It was hypothesized that:

There is no statistical significant effects of a scapular vupward rotation exercise (SURE) on scapular alignment in subjects with scapular downward rotation syndrome (SDRS).

There is no statistical significant effects a scapular upward rotation exercise (SURE) on mechanosensitivity of the upper limb peripheral nervous system in a depressed scapular alignment subjects.

There is no statistical significant effects a scapular upward rotation exercise (SURE) on pressure Pain Threshold in a depressed scapular alignment subjects.

There is no statistical significant effects a scapular upward rotation exercise (SURE)on Strenght Duration Curve measurement in a depressed scapular alignment subjects.

Study Overview

• Status: Unknown
• Conditions: Scapular Dyskinesis
• Intervention / Treatment: Other: Upward rotation exercise

Detailed Description

This study was conducted to investigate the effects of scapular upward rotation exercises on strength duration curve and pressure pain threshold (PPT) in subjects with scapular downward rotation syndrome.

Thirty subjects with age range of 18 to 30 years with scapular downward rotation were recruited in this study.

Thirty subjects of both gender with scapular downward rotation were recruited in this study.

All recruited subjects were examined to exclude defined pathological conditions.

All subjects were assessed by screening examination for downward rotation of scapula.

Pressure pain threshold was measured using pressure algometer. Mechanosensitivity of neural tissue was measured using neurodynamic test. Pain was measured using strength-duration (SD) curve. Treatment program consisted of 3 sessions/week, for 6 weeks. All measurements were taken pre and post the treatment period.

• Study Type: Interventional
• Enrollment (Anticipated): 30
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Doha Al-Afifi; Phone Number: 01003169353; Email: doha.h.afifi@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 30 years (ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• University population were screened for subjects with scapular downward rotation, those who met the following criteria was recruited in this study. The inclusion criteria for subject selection in this study was based on the literature (Caldwell et al., 2007; Ha et al., 2011) which included:

  1. The scapula was downwardly rotated by visual appraisal.We examined the root of spine of scapulae (superior angle) and inferior angle of scapulae. If scapulae was downwardly rotated, inferior angle closer to spine than root of spine of scapulae (superior angle).
  2. The clavicle appeared to be horizontal or the acromioclavicular joint was lower than the sternoclavicular joint by visual appraisal.
  3. The vertebral borders of the scapula was less than 3 inches from the spine by tape measure.

Exclusion Criteria:

• Subject who has any of the following criteria was excluded from the study:

  1. Subjects with cervical spinal fractures.
  2. Neck-rotation ROM of <20º.
  3. Radiating pain to an upper extremity.
  4. Scoliosis.
  5. Leg length discrepancy.
  6. A history of unresolved cancer.
  7. Diabetes Miletus.
  8. Polyneuropathy.
  9. Myofascial Pain Syndrome.
  10. Fibromyalgia.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: NA
• Interventional Model: SINGLE_GROUP
• Masking: NONE

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: one group; The treatment program consisted of upward rotation exercises for 3 sessions/week, for 6 weeks.	Other: Upward rotation exercise; Treatment for correction of depressed scapular Alignment by exercise ( Upward Rotation Exercises) for 6 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Neural excitability	Neural excitability measured by Strenght-duration cruve.	Strenght-duration curve for neural excitability is measured before starting the treatment.Strenght-duration is measured after application of 6 weeks treatment program.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pressure pain threshold	Pressure pain threshold was measured using pressure algometer.	All measurements were taken pre and post the treatment period (6 weeks).

Collaborators and Investigators

• Sponsor: Cairo University
• Investigators: Study Chair: Ragiaa Kamel, Basic Science Department, Faculty of Physical Therapy, Cairo University; Study Director: Amr Shalaby, Basic Science Department, Faculty of Physical Therapy, Cairo University

Study record dates

Study Major Dates

• Study Start (ANTICIPATED): February 28, 2021
• Primary Completion (ANTICIPATED): May 30, 2021
• Study Completion (ANTICIPATED): August 1, 2021

Study Registration Dates

• First Submitted: February 6, 2021
• First Submitted That Met QC Criteria: February 24, 2021
• First Posted (ACTUAL): March 1, 2021

Study Record Updates

• Last Update Posted (ACTUAL): March 1, 2021
• Last Update Submitted That Met QC Criteria: February 24, 2021
• Last Verified: February 1, 2021

More Information

Terms related to this study

• Keywords: Neural tissue mechanosensitivity; Depressed Scapular Alignment; Scapular upward rotation exercises
• Additional Relevant MeSH Terms: Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Movement Disorders; Dyskinesias
• Other Study ID Numbers: P.T.REC/012/002640

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: I commit to share the results of this study within 3-6 months of publicatin.
• IPD Sharing Time Frame: I commit to share the results of this study within 3-6 months of publication.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No